CYP2E1-IN-1, CAS [[38205-55-9]]

Produktübersicht

• Artikelname: CYP2E1-IN-1, CAS [[38205-55-9]]
• Artikelnummer: MCE-HY-W072025
• Hersteller Artikelnummer: HY-W072025
• Alternativnummer: MCE-HY-W072025-500MG,MCE-HY-W072025-250MG,MCE-HY-W072025-100MG,MCE-HY-W072025-1G,MCE-HY-W072025-10MMX1ML,MCE-HY-W072025-5G
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

CYP2E1-IN-1 (Compound 10) is an orally active cytochrome P450 2E1 (CYP2E1) inhibitor with a Kd of 7.02 µM, an IC50 of 1.64 µM, and a Ki of 0.897 µM. CYP2E1-IN-1 activates the Nrf2/HO-1 signaling pathway and inhibits ROS production, thereby alleviating pancreatic injury. CYP2E1-IN-1 has significant anti-inflammatory and antioxidant activities and can effectively reduce inflammation and oxidative stress in severe acute pancreatitis (SAP). CYP2E1-IN-1 can be used in the study of SAP and other inflammatory-related diseases[1].

Produkteigenschaften

• Molekulargewicht: 141.19
• Reinheit: 99.95
• CAS Nummer: [38205-55-9]
• Formel: C6H7NOS
• Target-Kategorie: Cytochrome P450,Heme Oxygenase (HO),Keap1-Nrf2,Reactive Oxygen Species (ROS)

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound